Delivery Order SPE2DB22D2206-SPE2DB25FEQ99

Award Date 12/11/24
Potential Completion Date 12/12/24
Potential Value $4.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FEQ99
    Delivery Order

This federal contract award was granted by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,097.80, is a Delivery Order for the provision of TRULICITY 4.5 MG/0.5 ML PEN 0.5ML, a prescription medication used for the treatment of diabetes. The contract has a firm fixed price and an ultimate completion date of December 12, 2024.

Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM.gov) and has an extensive history of providing pharmaceutical products and medical supplies to various federal agencies, particularly within the military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for delivering a comprehensive range of essential medical commodities to support military healthcare programs globally.

Generated 3/12/25, 10:14 AM